Furthermore, we explored the clinical relationship between RBPJ and DAPK3 and found that there was a positive correlation between RBPJ and DAPK3 in renal clear cell carcinoma, bladder cancer, pancreatic cancer, and liver cancer (Fig. 5k). This evidence concerns the gene RBPJ and urinary bladder cancer.